drugset / Trial / NCT00471029
Compare Efficacy of Gastric Acid Suppression by Oral and Intravenous Administration of Esomeprazole in Patients With Peptic Ulcer
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to compare the gastric acid suppression profile among different regimen (Oral Vs Intravenous)of administration of proton pump inhibitor - Esomeprazole by 24hours intragastric pH monitoring.
Timeline
- Start
- 2005-09
- Primary completion
- —
- Completion
- 2007-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Esomeprazole | Small molecule | 8 mg | Intravenous |
| Subject | Esomeprazole | Small molecule | 40 mg | Intravenous |